Source link : https://www.newshealth.biz/health-news/new-data-shed-light-on-who-stops-using-glp-1-drugs-and-why/
A majority of people with overweight or obesity prescribed glucagon-like peptide 1 receptor agonists (GLP-1 RAs) discontinue them within 1 year, with higher quit rates among those without type 2 diabetes (T2D), new research suggested. The data, from electronic health records of more than 125,000 adults who initiated GLP-1 RA treatment in the United States, […]
Author : News Health
Publish date : 2025-02-03 11:10:22
Copyright for syndicated content belongs to the linked Source.